DNATURE BIO LABS
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $3M
Investors
- 1
About DNATURE BIO LABS
Based in Seoul, South Korea, and founded in 2016, DNATURE BIO LABS began as a functional food and beverage business and is currently developing cell therapies for degenerative nervous system diseases. The company develops and manufactures functional food fit to consumers for each age group, gender, and occupational group. The company provides functional food and beverage containing ingredients that activate brain function to help prevent dementia and attention deficit hyperactivity disorder or ADHD, and enhances antioxidants and anti-inflammatory agents in order to develop immunity. The company is developing a dementia drug called LMTX, which targets Alzheimer's disease causing Tau protein. DNATURE BIO LABS is in the process of contracting for the multinational pharmaceutical company TauRx Pharmaceuticals to systematically transfer rights for domestic distribution, intellectual property rights, and clinical licenses of dementia treatment drugs particularly LMTX.
Who invested in DNATURE BIO LABS
1 investor across 1 round
See all investors in DNATURE BIO LABS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 29, 2021
Amount
$3M
Investors
Questions about DNATURE BIO LABS
Who invested in DNATURE BIO LABS?
DNATURE BIO LABS has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DNATURE BIO LABS raised?
DNATURE BIO LABS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DNATURE BIO LABS last raise money?
DNATURE BIO LABS's most recent round on record is a Series A, in Jul 2021.
What does DNATURE BIO LABS do?
Based in Seoul, South Korea, and founded in 2016, DNATURE BIO LABS began as a functional food and beverage business and is currently developing cell therapies for degenerative nervous system diseases.
Where is DNATURE BIO LABS headquartered?
DNATURE BIO LABS is headquartered in Seoul, South Korea.
Which VCs invest in companies like DNATURE BIO LABS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at DNATURE BIO LABS's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like DNATURE BIO LABS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.